| abstract |
The present invention relates to novel sulfonamide Nav1.7 inhibitors and pharmaceutically acceptable salts thereof, their use in medicine, compositions containing them, methods for their preparation, and in such methods Relates to the intermediate used. Nav1.7 inhibitors are potentially useful in the treatment of a wide range of diseases, particularly pain. |